RL vs TERN
Ralph Lauren Corp Class A (RL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported RL revenue for 2025-03-29 was $7.08B. Net income was $742.9M. Revenue was up 6.7% from 2024-03-30 to 2025-03-29. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
RL currently screens at market cap $16.95B and trailing P/E 24.1. TERN currently screens at market cap $6.12B.
Not investment advice. Open the RL and TERN stock pages for the full models.
Not investment advice.